Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 540

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 1
Chunk 540
---
 than ten business days prior to the end of the Second Compliance Period in order to timely regain
compliance. If we fail to regain compliance with the Bid Price Rule within the Second Compliance Period, or if we fail to continue to
meet all applicable continued listing requirements for Nasdaq in the future, Nasdaq could delist our common stock.

The Second Nasdaq Bid Price Letter
has no immediate effect on the listing or trading of our common stock. Our common stock continues to be listed on the Nasdaq Capital Market
under the symbol “XAIR”. We are currently evaluating our options for regaining compliance.

Available Information

We file electronically with the
Securities and Exchange Commission (the “SEC”) our annual reports on Form 10-K, quarterly reports on Form 10-Q and current
reports on Form 8-K, and amendments related thereto, pursuant to Section 13(a) or 15(d) of the Exchange Act. We make available on our
website at www.beyondair.net free of charge, copies of these reports, as soon as reasonably practicable after we electronically file such
material with, or furnish it to, the SEC. Reports filed with the SEC may be viewed at www.sec.gov. The information in or accessible through
the SEC and our website is not incorporated into, and is not considered part of, this filing. Further, our references to the URLs for
these websites are intended to be inactive textual references only.

Human Capital 

As of March 31, 2025, we had 61
employees globally, all of whom were full-time employees. None of our employees are represented by a labor union and we consider our employee
relations to be good.

Our workforce is highly educated
and diverse, which we believe is important for our continued success as a leading innovator in the medical device market. We employ a
number of strategies to best enable us to attract, retain, and engage our team members. Our human capital resources objectives include,
as applicable, identifying, recruiting, retaining, and incentivizing our management team and our clinical, scientific and other employees
and consultants. The principal purposes of our equity and cash incentive plans are to attract, retain and motivate personnel through the
granting of stock-based and cash-based compensation awards, in order to align our interests and the interests of our stockholders with
those of our employees and consultants.

30

ITEM 1A. RISK FACTORS

Investing in our common stock involves a high degree
of risk. You